Autism

Guidelines for Designing Consent Materials and Procedures For Autistic Adults and People with Intellectual Disability

NEW ROCHELLE, N.Y., Feb. 27, 2025 /PRNewswire/ -- A new article in Autism and Adulthood presents guidelines for designing consent materials…

3 weeks ago

SciSparc Extends $2 Million Loan to Support AutoMax’s Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles

TEL AVIV, Israel, Feb. 27, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage…

3 weeks ago

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results

Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in…

4 weeks ago

Brighter Strides ABA Expands Services with New Clinic Opening in Maryland

Providing Compassionate, Individualized ABA Therapy for Children with AutismCatonsville, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Brighter Strides ABA is…

4 weeks ago

Lighthouse Autism Center Announces Expansion of ABA Services in Nebraska 

Leading ABA Provider Set to Open Newest Location in Lincoln, NE. Therapy Room at LAC Therapy Room at LAC Therapy…

1 month ago

Nabla Named to the 2025 New York Digital Health 100 by Digital Health New York (DHNY)

DH100 recognizes those companies that have helped make New York the capital of healthcare innovation NEW YORK, Feb. 11, 2025…

1 month ago

DIGITAL celebrates continued investments in Canadian genomics

VANCOUVER, BC, Feb. 5, 2025 /CNW/ - DIGITAL, Canada's Global Innovation Cluster for digital technologies, is celebrating its ongoing impact…

1 month ago

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical…

1 month ago

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

1 month ago

TeachTown’s enCORE Named Primary & Secondary Education Category Winners in the Tech & Learning Awards of Excellence: Best of 2024

WOBURN, Mass., Jan. 31, 2025 /PRNewswire/ -- TeachTown, a leading provider of special education curriculum for students with moderate to…

2 months ago